These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012. Lee JSF; Sagaon Teyssier L; Dongmo Nguimfack B; Collins IJ; Lallemant M; Perriens J; Moatti JP BMC Pediatr; 2016 Mar; 16():41. PubMed ID: 26979974 [TBL] [Abstract][Full Text] [Related]
4. Do national drug policies influence antiretroviral drug prices? Evidence from the Southern African Development community. Liu Y; Galárraga O Health Policy Plan; 2017 Mar; 32(2):170-177. PubMed ID: 28207060 [TBL] [Abstract][Full Text] [Related]
5. Reforming antiretroviral price negotiations and public procurement: the Mexican experience. Adesina A; Wirtz VJ; Dratler S Health Policy Plan; 2013 Jan; 28(1):1-10. PubMed ID: 22375026 [TBL] [Abstract][Full Text] [Related]
6. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. Nunn AS; Fonseca EM; Bastos FI; Gruskin S; Salomon JA PLoS Med; 2007 Nov; 4(11):e305. PubMed ID: 18001145 [TBL] [Abstract][Full Text] [Related]
7. Negotiating antiretroviral drug prices: the experience of the Andean countries. Seoane-Vazquez E; Rodriguez-Monguio R Health Policy Plan; 2007 Mar; 22(2):63-72. PubMed ID: 17299024 [TBL] [Abstract][Full Text] [Related]
8. Prices & availability of common medicines at six sites in India using a standard methodology. Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500 [TBL] [Abstract][Full Text] [Related]
9. Examining the production costs of antiretroviral drugs. Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939 [TBL] [Abstract][Full Text] [Related]
10. Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs. Holmes CB; Coggin W; Jamieson D; Mihm H; Granich R; Savio P; Hope M; Ryan C; Moloney-Kitts M; Goosby EP; Dybul M JAMA; 2010 Jul; 304(3):313-20. PubMed ID: 20639565 [TBL] [Abstract][Full Text] [Related]
11. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. ; ; . PubMed ID: 20950492 [TBL] [Abstract][Full Text] [Related]